Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Coagulopathy Management with Calcium and Blood Products

Calcium Administration

  • Calcium should be routinely administered during massive transfusion to maintain ionized calcium levels >0.9 mmol/L, as hypocalcemia develops due to citrate in blood products binding calcium 1
  • Ionized calcium is essential for fibrin polymerization and platelet function; decreased levels impair coagulation and reduce cardiac contractility and systemic vascular resistance 1
  • Hypocalcemia correlates significantly with the amount of fresh frozen plasma transfused and infused colloids 1
  • Citrate metabolism may be severely impaired in patients with hypoperfusion, hypothermia, or hepatic insufficiency, increasing the risk of hypocalcemia 1

Fresh Frozen Plasma (FFP) Use

  • FFP contains approximately 70% of normal levels of all clotting factors but shows great variability between preparations 1
  • FFP is recommended for initial administration in patients with massive bleeding 1
  • An optimal plasma:red blood cell ratio of at least 1:2 is suggested for ongoing transfusion 1
  • FFP should be avoided in patients without substantial bleeding 1
  • FFP is not effective for reversing the antiplatelet effects of aspirin 2
  • When using FFP, be aware of potential complications including transfusion-related acute lung injury, infections, multiple organ failure, and acute respiratory distress syndrome 1, 3